menuBe part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free
  1. Home
  2. Programs
  3. Focus on Future Medicine and Genetics

Are Microbicides the Next Breakthrough in HIV?

ReachMD Healthcare Image
Restart
Resume
Choose a format
Media formats available:
Completing the pre-test is required to access this content.
Completing the pre-survey is required to view this content.

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Details
Presenters
Comments
  • Overview

    HIV research has encountered quite a few setbacks, especially with attempts to create an HIV vaccination. But topical microbicides made from glycerol monolaurate, commonly found in some foods and cosmetics, are showing some promise. What mechanisms of microbicides may help successfully prevent infection, including HIV and other sexually transmitted infections? Dr. Patrick Schlievert, professor of microbiology and immunology at the University of Minnesota Medical School, explains the exciting potential of topical microbicides for preventing the transmission of sexually transmitted infections and HIV. How soon might one of these topical microbicides be available, if they are further proved to have efficacy? Dr. Lee Freedman hosts.

Recommended
Details
Presenters
Comments
  • Overview

    HIV research has encountered quite a few setbacks, especially with attempts to create an HIV vaccination. But topical microbicides made from glycerol monolaurate, commonly found in some foods and cosmetics, are showing some promise. What mechanisms of microbicides may help successfully prevent infection, including HIV and other sexually transmitted infections? Dr. Patrick Schlievert, professor of microbiology and immunology at the University of Minnesota Medical School, explains the exciting potential of topical microbicides for preventing the transmission of sexually transmitted infections and HIV. How soon might one of these topical microbicides be available, if they are further proved to have efficacy? Dr. Lee Freedman hosts.

Schedule9 Sep 2024